A document on hospital drug purchasing in China was released Saturday, which instructed that hospitals should only source drugs from provincial pharmaceutical procurement platforms, reports the state-owned Xinhua news service.
The "significant" document, released by the State Council General Office, will aid hospital reform, regulate medicine supply and improve state policies in this regard, according to an accompanying statement.
Legal violations should be dealt with "harshly”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze